Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T Burkman

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
American Journal of Obstetrics and Gynecology|March 1, 1993
Lipid metabolism effects with desogestrel-containing oral contraceptivesR T Burkman
American Journal of Obstetrics and Gynecology|August 25, 2001
Introduction. The hormone continuum: accrual of women's health benefitsR T Burkman
Minerva Ginecologica|April 25, 2003
Hormone replacement therapy. Current controversiesR T Burkman
Clinical Obstetrics and Gynecology|February 24, 2001
Oral contraceptives: current statusR T Burkman
American Journal of Obstetrics and Gynecology|December 1, 1980
Intrauterine device use and the risk of pelvic inflammatory diseaseR T Burkman
International Journal of Fertility and Women'S Medicine|June 1, 2000
Cardiovascular issues with oral contraceptives: evidenced-based medicineR T Burkman
Dialogues in Contraception|April 1, 1997
Contraceptive sterilization: trends, options, and surprising new dataR T Burkman
International Journal of Fertility and Women'S Medicine|January 1, 1997
The estrogen component of OCs: cardiovascular benefits and risksR T Burkman
American Journal of Obstetrics and Gynecology|May 1, 1994
Noncontraceptive effects of hormonal contraceptives: bone mass, sexually transmitted disease and pelvic inflammatory disease, cardiovascular disease, menstrual function, and future fertilityR T Burkman
The American Journal of Medicine|January 16, 1995
The role of oral contraceptives in the treatment of hyperandrogenic disordersR T Burkman
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
American Journal of Obstetrics and Gynecology|March 1, 1993
Lipid metabolism effects with desogestrel-containing oral contraceptivesR T Burkman
American Journal of Obstetrics and Gynecology|August 25, 2001
Introduction. The hormone continuum: accrual of women's health benefitsR T Burkman
Minerva Ginecologica|April 25, 2003
Hormone replacement therapy. Current controversiesR T Burkman
Clinical Obstetrics and Gynecology|February 24, 2001
Oral contraceptives: current statusR T Burkman
American Journal of Obstetrics and Gynecology|December 1, 1980
Intrauterine device use and the risk of pelvic inflammatory diseaseR T Burkman
International Journal of Fertility and Women'S Medicine|June 1, 2000
Cardiovascular issues with oral contraceptives: evidenced-based medicineR T Burkman
Dialogues in Contraception|April 1, 1997
Contraceptive sterilization: trends, options, and surprising new dataR T Burkman
International Journal of Fertility and Women'S Medicine|January 1, 1997
The estrogen component of OCs: cardiovascular benefits and risksR T Burkman
American Journal of Obstetrics and Gynecology|May 1, 1994
Noncontraceptive effects of hormonal contraceptives: bone mass, sexually transmitted disease and pelvic inflammatory disease, cardiovascular disease, menstrual function, and future fertilityR T Burkman
The American Journal of Medicine|January 16, 1995
The role of oral contraceptives in the treatment of hyperandrogenic disordersR T Burkman
Pageof 9